Akari Therapeutics Plc – Transcripts

NASDAQ: AKTX
Share price (11/6/26): $7.37
Market cap (11/6/26): $16.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 06/17/26 Akari Therapeutics, Plc - Special Call 06/03/26

Other Revised 02/11/26 Akari Therapeutics, Plc - Special Call 02/10/26

CY 2025

Other Revised 11/18/25 Akari Therapeutics, Plc - Shareholder/Analyst Call 11/18/25

Other Revised 09/09/25 Akari Therapeutics, Plc - Special Call 09/04/25

Other Revised 06/26/25 Akari Therapeutics, Plc - Special Call 06/24/25

CY 2023

Other Revised 05/22/23 Akari Therapeutics, Plc - Special Call 05/22/23

CY 2020

Other Revised 08/31/20 Akari Therapeutics, Plc - Special Call 08/31/20

CY 2017

Other Revised 12/10/17 Akari Therapeutics, Plc - Shareholder/Analyst Call 12/10/17